MediData

By Laura Lovett July 26, 2018
WebMD goes to China. WebMD is teaming up with Chinese tech giant Tencent in a deal that would introduce the health information platform to Asia. This means that WebMD’s services will be translated into Chinese and localized to suit the Chinese population.  “The agreement between WebMD and Tencent has the power to make a difference in the health of the Chinese people,” said Meng Zhang, general...
By Dave Muoio July 25, 2018
Clinical trial technology company Medidata boasted consistent gains in revenue and income for the second quarter of 2018 during yesterday’s earnings call to investors. Referencing these numbers, last month’s acquisition of Shyft Analytics, recent high-profile contracts, and increased recognition from industry analysts, Medidata CEO and Chairman Tarek Sherif said that his company is performing...
By Jonah Comstock June 28, 2018
Dr. Joshua Mandel has left his position at Alphabet's Verily as health IT ecosystem lead for a position as chief architect at Microsoft Healthcare. Mandel isn't the only big name Microsoft just picked up; Jim Weinstein, former CEO of Dartmouth-Hitchcock, joined the company at the same time as VP and head of innovation and health equity. "Jim and Josh join us at an exciting time, as healthcare...
By Dave Muoio June 12, 2018
Medidata, a New York City-based company that offers cloud storage and data analytics services for clinical trials, announced today that it has acquired Shyft Analytics, maker of a cloud data analytics platform specifically designed for the pharma and biotech industries. The transaction valued Shyft at $195 million, inclusive of Medidata’s prior 6 percent ownership in the analytics platform, to be...
By Dave Muoio February 9, 2018
During an earnings call yesterday, executives of the clinical trial technology company Medidata heralded a digital shift in novel drug investigations, announcing that the company’s virtual trial platform, Engage, will now be offered as part of its Clinical Cloud product, and that a virtual trial powered by the company’s technology and recruiting an estimated 15,000 or more participants is now...
By Jonah Comstock July 19, 2017
Oscar Health is working with Humana to offer commercial health insurance to small businesses in a nine-county Nashville, Tenn. area. Tech-saavy insurance startup Oscar is teaming up with incumbent Humana at a time when it’s just begun to expand from the individual market into working with employers through its Oscar for Business unit. Humana will provide licenses to operate in Nashville as well...
By Heather Mack July 6, 2017
San Francisco-based Mendel.ai, a startup that is developing an artificial intelligence-powered platform to match people with cancer to clinical trials, has raised $2 million in seed funding from DCM Ventures, BootstrapLabs, Indie Bio, LaunchCapital and SOSV. Medel.ai will use the capital to forge partnerships with hospitals and cancer genomics companies to bring the system into use. For $99,...
By Heather Mack April 27, 2017
New York-based Fit4D, which offers digital coaching for people with diabetes, is partnering with global diabetes data management company Glooko to bring a more data-driven approach to their mobile patient engagement tools. The pairing will give Fit4D’s coaches access to Glooko’s device-agnostic platform, which people with diabetes see in the form of a mobile app they can use to automatically sync...
By Jonah Comstock April 24, 2017
Medidata, a New York City-based company that offers cloud storage and data analytics services for clinical trials, announced last week its plans to acquire Mytrus, a clinical trial technology company focused on patient-focused electronic informed consent and remote trials. The terms of the acquisition were not disclosed. “The informed consent process is one of the most important parts of running...
By Heather Mack October 19, 2016
IBM has partnered with Quest Diagnostics to launch a new precision medicine service that blends cognitive computing with genomic tumor sequencing. The service, IBM Watson Genomics from Quest Diagnostics, allows a physician to send a tissue sample to Quest, which will sequence the tumor DNA and send the genetic data through Watson for analysis. Watson runs through its reposititory of literature,...